| GA23380-5mg |
|
— |
Prepro-Killer Cell Immunoglobulin-Like Receptor 3DL3 (23-31)
|
0 |
C44H69N11O13 |
|
|
|
| GA23380-1mg |
|
— |
Prepro-Killer Cell Immunoglobulin-Like Receptor 3DL3 (23-31)
|
0 |
C44H69N11O13 |
|
|
|
| GA23379-005mg |
|
112199-06-1 |
Prepro-Atrial Natriuretic Factor (56-92) (human)
|
0 |
C173H270N44O57 |
|
|
|
| GA23378-005mg |
|
112160-82-4 |
Prepro-Atrial Natriuretic Factor (26-55) (human)
|
0 |
C152H236N38O51S3 |
|
|
|
| GA23377-5mg |
|
112160-83-5 |
Prepro-Atrial Natriuretic Factor (104-123) (human)
|
0 |
C94H171N31O28 |
|
|
|
| GA23377-1mg |
|
112160-83-5 |
Prepro-Atrial Natriuretic Factor (104-123) (human)
|
0 |
C94H171N31O28 |
|
|
|
| GA23376-5mg |
|
107902-86-3 |
Prepro VIP (156-170) (human)
|
0 |
C71H106N16O31 |
|
|
|
| GA23376-1mg |
|
107902-86-3 |
Prepro VIP (156-170) (human)
|
0 |
C71H106N16O31 |
|
|
|
| GA23375-25mg |
|
102813-98-9 |
Preangiotensinogen (11-14) (human)
|
0 |
C21H35N7O6 |
|
|
|
| GA23375-5mg |
|
102813-98-9 |
Preangiotensinogen (11-14) (human)
|
0 |
C21H35N7O6 |
|
|
|
| GA23374-1mg |
|
229030-20-0 |
Polyphemusin II-Derived Peptide
|
0 |
C90H141N33O18S2 |
|
|
|
| GA23374-005mg |
|
229030-20-0 |
Polyphemusin II-Derived Peptide
|
0 |
C90H141N33O18S2 |
|
|
|
| GA23373-1mg |
|
872043-01-1 |
|
0 |
C78H132N20O19 |
|
|
|
| GA23373-005mg |
|
872043-01-1 |
|
0 |
C78H132N20O19 |
|
|
|
| GA23372-5g |
|
185674-98-0 |
|
0 |
C16H24N2O3S2 |
|
|
|
| GA23372-1g |
|
185674-98-0 |
|
0 |
C16H24N2O3S2 |
|
|
|
| GA23371-5mg |
|
126370-52-3 |
|
0 |
C85H149N31O24 |
|
|
|
| GA23371-1mg |
|
126370-52-3 |
|
0 |
C85H149N31O24 |
|
|
|
| GA23370-1g |
|
77697-23-5 |
p-Hydroxyhippuryl-His-Leu-OH
|
0 |
C21H27N5O6 |
|
|
|
| GA23370-250mg |
|
77697-23-5 |
p-Hydroxyhippuryl-His-Leu-OH
|
0 |
C21H27N5O6 |
|
|
|
